Expertise in
24
conditions

Dr. Norman E. Lepor

Cardiology
99 N La Cienega Blvd, 
Beverly Hills, CA 
Accepting New Patients
Offers Telehealth
44 Years of Experience
Referral may be required
Before you request
Expertise in
24
conditions
99 N La Cienega Blvd, 
Beverly Hills, CA 

Overview

Norman Lepor is a Cardiologist practicing medicine in Beverly Hills, California. He has been practicing medicine for over 44 years.

Dr. Lepor is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, Angina, and High Cholesterol.

Dr. Lepor is board certified in American Board Internal Medicine. He is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 10 clinical trials. Dr. Lepor is currently accepting new patients.

Graduate Year

1982

Specialties

Cardiology

Licenses

Specialist in CA

Board Certifications

American Board Internal Medicine

Fellowships

Cedars Sinai Medical Center , Cardiology , 1985 - 1988

Hospital Affiliations

Cedars-Sinai Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Westside Medical Associates
99 N La Cienega Blvd, Beverly Hills, CA 90211

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Completed
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Mixed Dyslipidemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Enrollment Status: Terminated
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
VITROS Immunodiagnostic Products NT-proBNP II
VITROS Immunodiagnostic Products NT-proBNP II
Enrollment Status: Completed
Publish Date: March 09, 2020
Intervention Type: Diagnostic test
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study
Enrollment Status: Unknown
Publish Date: April 26, 2019
Intervention Type: Drug
Study Drug: Alirocumab
Study Phase: Phase 4
View 9 Less Clinical Trials

55 Total Publications

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
Journal: The New England journal of medicine
Published: March 25, 2026
Similar Doctors
Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Office

100 Medical Plz E Ste 630, 
Los Angeles, CA 
 (3.8 miles away)
310-825-8816
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregg Fonarow is a Cardiologist practicing medicine in Los Angeles, California. Dr. Fonarow is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Attack, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Thrombectomy. Dr. Fonarow is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required
Before you request

Office

8536 Wilshire Blvd, 
Beverly Hills,, CA 
 (0.2 miles away)
310-248-8300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michelle Kittleson is a Cardiologist practicing medicine in Beverly Hills,, California. Dr. Kittleson is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Stent Placement. Dr. Kittleson is currently accepting new patients.

Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required
Before you request

Cedars-Sinai Electrophysiology Program

127 S San Vicente Blvd Ste A3600, 
Los Angeles,, CA 
 (0.4 miles away)
310-423-3851
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Siegel is a Cardiologist practicing medicine in Los Angeles,, California. Dr. Siegel is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Aortic Regurgitation, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Siegel is currently accepting new patients.

Frequently Asked Questions about Dr. Norman E. Lepor

How do I make an appointment with Dr. Norman E. Lepor?

You can book an appointment with Dr. Norman E. Lepor by calling their office at 310-289-9955. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Norman E. Lepor a top-rated expert for Atherosclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Norman E. Lepor is classified as an Distinguished expert for Atherosclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Norman E. Lepor specialize in?

While Dr. Norman E. Lepor is a Cardiology, they have specific expertise in Atherosclerosis, Coronary Heart Disease, and Angina. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Norman E. Lepor participate in research or clinical trials?

Yes. Dr. Norman E. Lepor has published 55 articles and abstracts on conditions like Atherosclerosis. You can view a list of Dr. Norman E. Lepor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Norman E. Lepor accept my insurance?

Dr. Norman E. Lepor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-289-9955 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lepor's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile